Open label, non controlled, non randomized, interventional pilot study to evaluate the response rate after induction therapy with Docetaxel (T)and Cisplatin (P) in unresectable locally advanced squamous cell carcinoma of head and neck

Next Previous
Trial Profile

Open label, non controlled, non randomized, interventional pilot study to evaluate the response rate after induction therapy with Docetaxel (T)and Cisplatin (P) in unresectable locally advanced squamous cell carcinoma of head and neck

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Mar 2018

At a glance

  • Drugs Cisplatin; Docetaxel
  • Indications Head and neck cancer
  • Focus Therapeutic Use

    • Most Recent Events

    • 29 Dec 2011 Status changed from recruiting to completed.
    • 03 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top